The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab (bev) for metastatic colorectal cancer (mCRC): A global cost-effectiveness analysis.
 
Daniel A. Goldstein
No Relationships to Disclose
 
Qiushi Chen
No Relationships to Disclose
 
Turgay Ayer
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose
 
Kiran Virik
No Relationships to Disclose
 
Ariel Hammerman
No Relationships to Disclose
 
Baruch Brenner
No Relationships to Disclose
 
Christopher Flowers
Consulting or Advisory Role - OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Peter Hall
No Relationships to Disclose